Literature DB >> 28280135

Homozygous mutation in NUP107 leads to microcephaly with steroid-resistant nephrotic condition similar to Galloway-Mowat syndrome.

Rasim Ozgur Rosti1, Bethany N Sotak1, Stephanie L Bielas2, Gifty Bhat3,4, Jennifer L Silhavy1, Ayca Dilruba Aslanger5, Umut Altunoglu6, Ilmay Bilge7, Mehmet Tasdemir7, Amanda D Yzaguirrem1, Damir Musaev1, Sofia Infante1, Whitney Thuong1, Isaac Marin-Valencia3, Stanley F Nelson8, Hulya Kayserili5,9, Joseph G Gleeson1,3.   

Abstract

BACKGROUND: Microcephaly with nephrotic syndrome is a rare co-occurrence, constituting the Galloway-Mowat syndrome (GAMOS), caused by mutations in WDR73 (OMIM: 616144). However, not all patients harbour demonstrable WDR73 deleterious variants, suggesting that there are other yet unidentified factors contributing to GAMOS aetiology.
METHODS: Autozygosity mapping and candidate analysis was used to identify deleterious variants in consanguineous families. Analysis of patient fibroblasts was used to study splicing and alterations in cellular function.
RESULTS: In two consanguineous families with five affected individuals from Turkey with a GAMOS-like presentation, we identified a shared homozygous variant leading to partial exon 4 skipping in nucleoporin, 107-KD (NUP107). The founder mutation was associated with concomitant reduction in NUP107 protein and in the obligate binding partner NUP133 protein, as well as density of nuclear pores in patient cells.
CONCLUSION: Recently, NUP107 was suggested as a candidate in a family with nephrotic syndrome and developmental delay. Other NUP107-reported cases had isolated renal phenotypes. With the addition of these individuals, we implicate an allele-specific critical role for NUP107 in the regulation of brain growth and a GAMOS-like presentation. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  FSGS; Galloway-Mowat syndrome; NUP107; microcephaly; steroid-resistant nephrotic syndrome

Mesh:

Substances:

Year:  2017        PMID: 28280135     DOI: 10.1136/jmedgenet-2016-104237

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  28 in total

1.  Nup133 Is Required for Proper Nuclear Pore Basket Assembly and Dynamics in Embryonic Stem Cells.

Authors:  Benoit Souquet; Ellen Freed; Alessandro Berto; Vedrana Andric; Nicolas Audugé; Bernardo Reina-San-Martin; Elizabeth Lacy; Valérie Doye
Journal:  Cell Rep       Date:  2018-05-22       Impact factor: 9.423

2.  Biallelic Variants in the Nuclear Pore Complex Protein NUP93 Are Associated with Non-progressive Congenital Ataxia.

Authors:  Ginevra Zanni; P De Magistris; M Nardella; E Bellacchio; S Barresi; A Sferra; A Ciolfi; M Motta; H Lue; D Moreno-Andres; M Tartaglia; E Bertini; Wolfram Antonin
Journal:  Cerebellum       Date:  2019-06       Impact factor: 3.847

3.  NUP188 Biallelic Loss of Function May Underlie a New Syndrome: Nucleoporin 188 Insufficiency Syndrome?

Authors:  Anna Sandestig; Karolina Engström; Alexander Pepler; Ingela Danielsson; Per Odelberg-Johnsson; Saskia Biskup; Anja Holz; Margarita Stefanova
Journal:  Mol Syndromol       Date:  2019-12-10

4.  Mutated NUP188 and Other Nucleoporins as Gateways to Developmental Syndromes.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2020-02-15

5.  Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome.

Authors:  Daniela A Braun; Svjetlana Lovric; David Schapiro; Ronen Schneider; Jonathan Marquez; Maria Asif; Muhammad Sajid Hussain; Ankana Daga; Eugen Widmeier; Jia Rao; Shazia Ashraf; Weizhen Tan; C Patrick Lusk; Amy Kolb; Tilman Jobst-Schwan; Johanna Magdalena Schmidt; Charlotte A Hoogstraten; Kaitlyn Eddy; Thomas M Kitzler; Shirlee Shril; Abubakar Moawia; Kathrin Schrage; Arwa Ishaq A Khayyat; Jennifer A Lawson; Heon Yung Gee; Jillian K Warejko; Tobias Hermle; Amar J Majmundar; Hannah Hugo; Birgit Budde; Susanne Motameny; Janine Altmüller; Angelika Anna Noegel; Hanan M Fathy; Daniel P Gale; Syeda Seema Waseem; Ayaz Khan; Larissa Kerecuk; Seema Hashmi; Nilufar Mohebbi; Robert Ettenger; Erkin Serdaroğlu; Khalid A Alhasan; Mais Hashem; Sara Goncalves; Gema Ariceta; Mercedes Ubetagoyena; Wolfram Antonin; Shahid Mahmood Baig; Fowzan S Alkuraya; Qian Shen; Hong Xu; Corinne Antignac; Richard P Lifton; Shrikant Mane; Peter Nürnberg; Mustafa K Khokha; Friedhelm Hildebrandt
Journal:  J Clin Invest       Date:  2018-09-04       Impact factor: 14.808

6.  De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis.

Authors:  Patricia L Weng; Amar J Majmundar; Kamal Khan; Tze Y Lim; Shirlee Shril; Gina Jin; John Musgrove; Minxian Wang; Dina F Ahram; Vimla S Aggarwal; Louise E Bier; Erin L Heinzen; Ana C Onuchic-Whitford; Nina Mann; Florian Buerger; Ronen Schneider; Konstantin Deutsch; Thomas M Kitzler; Verena Klämbt; Amy Kolb; Youying Mao; Christelle Moufawad El Achkar; Adele Mitrotti; Jeremiah Martino; Bodo B Beck; Janine Altmüller; Marcus R Benz; Shoji Yano; Mohamad A Mikati; Talha Gunduz; Heidi Cope; Vandana Shashi; Howard Trachtman; Monica Bodria; Gianluca Caridi; Isabella Pisani; Enrico Fiaccadori; Asmaa S AbuMaziad; Julian A Martinez-Agosto; Ora Yadin; Jonathan Zuckerman; Arang Kim; Ulrike John-Kroegel; Amanda V Tyndall; Jillian S Parboosingh; A Micheil Innes; Agnieszka Bierzynska; Ania B Koziell; Mordi Muorah; Moin A Saleem; Julia Hoefele; Korbinian M Riedhammer; Ali G Gharavi; Vaidehi Jobanputra; Emma Pierce-Hoffman; Eleanor G Seaby; Anne O'Donnell-Luria; Heidi L Rehm; Shrikant Mane; Vivette D D'Agati; Martin R Pollak; Gian Marco Ghiggeri; Richard P Lifton; David B Goldstein; Erica E Davis; Friedhelm Hildebrandt; Simone Sanna-Cherchi
Journal:  Am J Hum Genet       Date:  2021-01-27       Impact factor: 11.025

7.  Mutations in WDR4 as a new cause of Galloway-Mowat syndrome.

Authors:  Daniela A Braun; Shirlee Shril; Aditi Sinha; Ronen Schneider; Weizhen Tan; Shazia Ashraf; Tobias Hermle; Tilman Jobst-Schwan; Eugen Widmeier; Amar J Majmundar; Ankana Daga; Jillian K Warejko; Makiko Nakayama; David Schapiro; Jing Chen; Merlin Airik; Jia Rao; Johanna Magdalena Schmidt; Charlotte A Hoogstraten; Hannah Hugo; Jitendra Meena; Monkol Lek; Kristen M Laricchia; Arvind Bagga; Friedhelm Hildebrandt
Journal:  Am J Med Genet A       Date:  2018-08-06       Impact factor: 2.802

8.  Loss of SMPD4 Causes a Developmental Disorder Characterized by Microcephaly and Congenital Arthrogryposis.

Authors:  Pamela Magini; Daphne J Smits; Laura Vandervore; Rachel Schot; Marta Columbaro; Esmee Kasteleijn; Mees van der Ent; Flavia Palombo; Maarten H Lequin; Marjolein Dremmen; Marie Claire Y de Wit; Mariasavina Severino; Maria Teresa Divizia; Pasquale Striano; Natalia Ordonez-Herrera; Amal Alhashem; Ahmed Al Fares; Malak Al Ghamdi; Arndt Rolfs; Peter Bauer; Jeroen Demmers; Frans W Verheijen; Martina Wilke; Marjon van Slegtenhorst; Peter J van der Spek; Marco Seri; Anna C Jansen; Rolf W Stottmann; Robert B Hufnagel; Robert J Hopkin; Deema Aljeaid; Wojciech Wiszniewski; Pawel Gawlinski; Milena Laure-Kamionowska; Fowzan S Alkuraya; Hanah Akleh; Valentina Stanley; Damir Musaev; Joseph G Gleeson; Maha S Zaki; Nicola Brunetti-Pierri; Gerarda Cappuccio; Bella Davidov; Lina Basel-Salmon; Lily Bazak; Noa Ruhrman Shahar; Aida Bertoli-Avella; Ghayda M Mirzaa; William B Dobyns; Tommaso Pippucci; Maarten Fornerod; Grazia M S Mancini
Journal:  Am J Hum Genet       Date:  2019-09-05       Impact factor: 11.025

Review 9.  Moonlighting nuclear pore proteins: tissue-specific nucleoporin function in health and disease.

Authors:  Ramona Jühlen; Birthe Fahrenkrog
Journal:  Histochem Cell Biol       Date:  2018-10-25       Impact factor: 4.304

10.  Gene set enrichment analysis and meta-analysis to identify six key genes regulating and controlling the prognosis of esophageal squamous cell carcinoma.

Authors:  Wenwu He; Linxin Chen; Kun Yuan; Qiuxi Zhou; Lin Peng; Yongtao Han
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.